200 related articles for article (PubMed ID: 29284499)
21. Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.
Hughes RK; Camaioni C; Augusto JB; Knott K; Quinn E; Captur G; Seraphim A; Joy G; Syrris P; Elliott PM; Mohiddin S; Kellman P; Xue H; Lopes LR; Moon JC
J Am Heart Assoc; 2021 Aug; 10(15):e020227. PubMed ID: 34310159
[TBL] [Abstract][Full Text] [Related]
22. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
[TBL] [Abstract][Full Text] [Related]
23. Association between left atrial myopathy and sarcomere mutation in patients with hypertrophic cardiomyopathy: insights into left atrial strain by MRI feature tracking.
Wang J; Ma X; Zhao K; Yang S; Yang K; Yu S; Yin G; Dong Z; Song Y; Cui C; Li J; Zhao S; Chen X
Eur Radiol; 2024 Feb; 34(2):1026-1036. PubMed ID: 37635167
[TBL] [Abstract][Full Text] [Related]
24. Diltiazem treatment for pre-clinical hypertrophic cardiomyopathy sarcomere mutation carriers: a pilot randomized trial to modify disease expression.
Ho CY; Lakdawala NK; Cirino AL; Lipshultz SE; Sparks E; Abbasi SA; Kwong RY; Antman EM; Semsarian C; González A; López B; Diez J; Orav EJ; Colan SD; Seidman CE
JACC Heart Fail; 2015 Feb; 3(2):180-8. PubMed ID: 25543971
[TBL] [Abstract][Full Text] [Related]
25. [Echocardiographic assessment of left atrial volume and emptying in hypertrophic cardiomyopathy].
Michalak E; Michalak JM; Chojnowska L; Ruzyłło W; Hoffman P
Przegl Lek; 2004; 61(6):729-32. PubMed ID: 15724674
[TBL] [Abstract][Full Text] [Related]
26. Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.
Sipola P; Magga J; Husso M; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Eur Radiol; 2011 Jul; 21(7):1383-9. PubMed ID: 21274714
[TBL] [Abstract][Full Text] [Related]
27. CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation.
Tarkiainen M; Sipola P; Jalanko M; Heliö T; Jääskeläinen P; Kivelä K; Laine M; Lauerma K; Kuusisto J
Sci Rep; 2019 Apr; 9(1):5960. PubMed ID: 30976029
[TBL] [Abstract][Full Text] [Related]
28. Hypertrophic Cardiomyopathy Patients With Paroxysmal Atrial Fibrillation Have a High Burden of Left Atrial Fibrosis by Cardiac Magnetic Resonance Imaging.
Sivalokanathan S; Zghaib T; Greenland GV; Vasquez N; Kudchadkar SM; Kontari E; Lu DY; Dolores-Cerna K; van der Geest RJ; Kamel IR; Olgin JE; Abraham TP; Nazarian S; Zimmerman SL; Abraham MR
JACC Clin Electrophysiol; 2019 Mar; 5(3):364-375. PubMed ID: 30898240
[TBL] [Abstract][Full Text] [Related]
29. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
30. Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and Overt Hypertrophic Cardiomyopathy.
Joy G; Kelly CI; Webber M; Pierce I; Teh I; McGrath L; Velazquez P; Hughes RK; Kotwal H; Das A; Chan F; Bakalakos A; Lorenzini M; Savvatis K; Mohiddin SA; Macfarlane PW; Orini M; Manisty C; Kellman P; Davies RH; Lambiase PD; Nguyen C; Schneider JE; Tome M; Captur G; Dall'Armellina E; Moon JC; Lopes LR
Circulation; 2023 Sep; 148(10):808-818. PubMed ID: 37463608
[TBL] [Abstract][Full Text] [Related]
31. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography.
Corona-Villalobos CP; Sorensen LL; Pozios I; Chu L; Eng J; Abraham MR; Abraham TP; Kamel IR; Zimmerman SL
Int J Cardiovasc Imaging; 2016 Jun; 32(6):945-54. PubMed ID: 26896038
[TBL] [Abstract][Full Text] [Related]
32. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
33. Abnormal septal convexity into the left ventricle occurs in subclinical hypertrophic cardiomyopathy.
Reant P; Captur G; Mirabel M; Nasis A; M Sado D; Maestrini V; Castelletti S; Manisty C; Herrey AS; Syrris P; Tome-Esteban M; Jenkins S; Elliott PM; McKenna WJ; Moon JC
J Cardiovasc Magn Reson; 2015 Jul; 17(1):64. PubMed ID: 26219660
[TBL] [Abstract][Full Text] [Related]
34. "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
Tondi L; Pica S; Crimi G; Disabato G; Figliozzi S; Camporeale A; Bernardini A; Tassetti L; Milani V; Piepoli MF; Lombardi M
Int J Cardiol; 2024 Aug; 408():132135. PubMed ID: 38705206
[TBL] [Abstract][Full Text] [Related]
35. Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy.
Ho CY; Carlsen C; Thune JJ; Havndrup O; Bundgaard H; Farrohi F; Rivero J; Cirino AL; Andersen PS; Christiansen M; Maron BJ; Orav EJ; Køber L
Circ Cardiovasc Genet; 2009 Aug; 2(4):314-21. PubMed ID: 20031602
[TBL] [Abstract][Full Text] [Related]
36. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular magnetic resonance myocardial feature tracking for the determination of left atrial strain in hypertensive left ventricular hypertrophy and hypertrophic cardiomyopathy.
Yao B; Wu R; Chen BH; Wesemann LD; Xu JR; Zhou Y; Wu LM
Clin Radiol; 2023 May; 78(5):e409-e416. PubMed ID: 36746719
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic cardiomyopathy: preclinical and early phenotype.
Ho CY
J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
[TBL] [Abstract][Full Text] [Related]
39. Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.
Rodrigues JC; Rohan S; Ghosh Dastidar A; Harries I; Lawton CB; Ratcliffe LE; Burchell AE; Hart EC; Hamilton MC; Paton JF; Nightingale AK; Manghat NE
Eur Radiol; 2017 Mar; 27(3):1125-1135. PubMed ID: 27368925
[TBL] [Abstract][Full Text] [Related]
40. Quantification of left atrial strain and strain rate using Cardiovascular Magnetic Resonance myocardial feature tracking: a feasibility study.
Kowallick JT; Kutty S; Edelmann F; Chiribiri A; Villa A; Steinmetz M; Sohns JM; Staab W; Bettencourt N; Unterberg-Buchwald C; Hasenfuß G; Lotz J; Schuster A
J Cardiovasc Magn Reson; 2014 Aug; 16(1):60. PubMed ID: 25196447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
